Economiic Home Method Watch Market RSI Search

Peak Bio, Inc. PKBO

Sector:

Healthcare

Industry:

Biotechnology

Description:

Peak Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics addressing unmet needs in the areas of oncology and inflammation. The company's proprietary toxin, PH-1 or Thailanstatin, a spliceosome modulator is being used to generate its first pipeline of novel ADC product candidates to address unmet needs in cancer patients. Its lead product candidate, PHP-303, is a small molecule awaiting Phase II dose clinical study in the orphan disease Alpha1 anti-trypsin deficiency (AATD). The company is based in Palo Alto, California.
Peak Bio, Inc. website

Recent Quarter:

2024-08-23

Upcoming Quarter:

N/A

Annual Reports

Date2024-08-06
Revenue 367,877
Net Income -1,259.2,602,097,000,001
EPS 0
Basic Shares 29,543,410
Diluted Shares 29,543,410
Report Link
Date2023-06-29
Revenue 607,681
Net Income -13,088,717
EPS -0.74
Basic Shares 17,711,842
Diluted Shares 17,711,842
Report Link
Date2021-12-31
Revenue 528,309
Net Income -8,292,576
EPS -0.48
Basic Shares 17,162,742
Diluted Shares 17,162,742
Report Link
Date2020-12-31
Revenue 0
Net Income -2,458.2,881,439
EPS -0.0004
Basic Shares 6,719,000
Diluted Shares 6,718,800
Report Link
Date2019-12-31
Revenue 0
Net Income -1,267.8,842,347,999,998
EPS -0.0003
Basic Shares 3,640,400
Diluted Shares 3,640,300
Report Link

Annual Ratios

Date2023-12-31
PE -4398.92
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-12-31
PE -5.67
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-12-31
PE -20.16
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-12-31
PE -26457.40
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-12-31
PE -27793.60
Dividend Yield 0.00
Payout Ratio: 0.000%

Quarterly Reports

Date2024-11-12
Revenue 0
Net Income 1,713,936
EPS 0.0603
Basic Shares 28,440,646
Diluted Shares 28,440,646
Report Link
Date2024-08-23
Revenue 0
Net Income -2,077,867
EPS 0
Basic Shares 23,124,888
Diluted Shares 23,124,888
Report Link
Date2024-08-23
Revenue 0
Net Income -2,434,701
EPS -0.11
Basic Shares 23,124,888
Diluted Shares 23,124,888
Report Link
Date2024-08-06
Revenue 75,192
Net Income -525,444
EPS -0.0227
Basic Shares 23,120,000
Diluted Shares 23,120,000
Report Link
Date2024-06-25
Revenue 278,831
Net Income 410,587
EPS 0.01
Basic Shares 35,966,820
Diluted Shares 35,966,820
Report Link
Date2023-08-18
Revenue 0
Net Income -5,944,227
EPS -0.29
Basic Shares 20,254,118
Diluted Shares 20,254,118
Report Link
Date2023-07-12
Revenue 13,854
Net Income -6,376,980
EPS -0.32
Basic Shares 19,837,782
Diluted Shares 19,837,782
Report Link
Date2023-06-29
Revenue 607,681
Net Income -13,192,900
EPS -0.74
Basic Shares 17,711,842
Diluted Shares 17,711,842
Report Link
Date2022-09-30
Revenue 0
Net Income -171,007
EPS -0.0085
Basic Shares 20,058,046
Diluted Shares 20,058,046
Report Link
Date2022-06-30
Revenue 0
Net Income -2,522,858
EPS -0.13
Basic Shares 20,058,046
Diluted Shares 20,058,046
Report Link
Date2022-03-31
Revenue 52,950
Net Income -2,100,435
EPS -0.1
Basic Shares 20,058,046
Diluted Shares 20,058,046
Report Link
Date2021-12-31
Revenue 528,309
Net Income -8,683,869
EPS -0.51
Basic Shares 17,162,742
Diluted Shares 17,162,742
Report Link
Date2021-09-30
Revenue 0
Net Income 121,369
EPS 0.0071
Basic Shares 17,162,742
Diluted Shares 20,058,046
Report Link

Quarterly Ratios

Date2024-09-30
PE 0.75
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2024-06-30
PE -0.03
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2024-03-31
PE -0.01
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-12-31
PE -2.06
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-09-30
PE 2.63
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-06-30
PE -0.71
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-03-31
PE -0.51
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-12-31
PE -1.41
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-09-30
PE -292.65
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-06-30
PE -19.60
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-03-31
PE -23.49
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-12-31
PE -4.81
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-09-30
PE 346.10
Dividend Yield 0.00
Payout Ratio: 0.000%

RSI:

40.91

Price:

$0.07

Market Cap:

531,873

EPS TTM:

-0.07

PE Ratio:

-0.20

PEPSG:

NaN

Fwd PE:

NaN

Volume:

2,001

2 Year Price Change

0.015

Index 2 Year Price Change

1.497

5 Year Price Change

No Price 5 Years Ago

Index 5 Year Price Change

1.905
PESPG: Growth Rate of EPS projected to next quarter and 6 months trailing. Lower is better to help calculate nexts quarters PE Ratio today. Diluted shares effects the EPS reported and makes calculation show as extremely poor expected growth.

Revenue

Net Income

EPS

Shares

News

Press Releases

Notable Earnings

Please select an option: